These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12659424

  • 1. Lymphokine-activated killer cells can kill target cells not only by early killing but also by late killing, and the late killing level against autotumor cell line.
    Komatsu F, Ishiguro K.
    Oncol Res; 2003; 13(4):235-41. PubMed ID: 12659424
    [Abstract] [Full Text] [Related]

  • 2. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

  • 3. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS, Kim CM, Lee JO, Kang TW, Yun TK, Kim CY.
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [Abstract] [Full Text] [Related]

  • 4. Cell-cell adhesion-independent killing due to lymphokine-activated killer cells against glioblastoma cell lines.
    Komatsu F, Masuda T.
    Oncol Res; 2000 Mar; 12(9-10):371-81. PubMed ID: 11697816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Natural killer (NK) and lymphokine-activated killer (LAK) activities in a patient who recovered from cancer, and the characteristics of LAK cells generated from CD4-CD8- and CD8+ peripheral blood lymphocytes.
    Komatsu F, Kihara K.
    Clin Immunol Immunopathol; 1995 Oct; 77(1):75-81. PubMed ID: 7554487
    [Abstract] [Full Text] [Related]

  • 11. Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model.
    Iwasaki K, Kikuchi H, Miyatake S, Aoki T, Yamasaki T, Oda Y.
    Cancer Res; 1990 Apr 15; 50(8):2429-36. PubMed ID: 2317827
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
    Bean P, Agah R, Mazumder A.
    J Biol Response Mod; 1990 Feb 15; 9(1):92-7. PubMed ID: 2181073
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Noguchi K, Tamai M, Hotta T, Mizobata S.
    Anticancer Res; 1993 Feb 15; 13(5C):1773-6. PubMed ID: 8267381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cell surface recognition determinants involved in triggering the lymphokine activated killer cell phenomenon: enhanced killing of modified "anti-self" targets by varying LAK culture conditions.
    Finkelstein DM, Miller RG.
    J Otolaryngol; 1990 Oct 15; 19(5):294-8. PubMed ID: 2262945
    [Abstract] [Full Text] [Related]

  • 19. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells.
    Miyake M, Horiuchi A, Kimura K, Abe Y, Kimura S, Hitsumoto Y.
    Eur J Immunol; 1992 Aug 15; 22(8):2147-52. PubMed ID: 1639109
    [Abstract] [Full Text] [Related]

  • 20. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX, Zhang XS, Xia JC, Li YQ, Xu RH, Han WJ, Zhang JH, Guan ZZ, Jiang WQ.
    Ai Zheng; 2007 Aug 15; 26(8):837-42. PubMed ID: 17697543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.